Active, Not Recruiting
Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
NCT04007029
- Conditions
- CD19 Positive, CD20 Positive, Chronic Disease, +33 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States